Intercalative Mode Research Articles

Evaluation of Antimicrobial, Antitumor, Antioxidant Activities, and Molecular Docking Studies of Some Co(II), Cu(II), Mn(II), Ni(II), Pd(II), and Pt(II) Complexes With a Schiff Base Derived From 2‐Chloro‐5‐(trifluoromethyl)aniline

ABSTRACTThe antimicrobial, antitumor and antioxidant potential of Co(II), Cu(II), Mn(II), Ni(II), Pd(II), and Pt(II) complexes with 2‐(((2‐chloro‐5‐(trifluoromethyl)phenyl)imino)methyl)phenol HL ligand was investigated. A molecular docking study was carried out to estimate the predicted binding affinity of the compounds to protein targets involved in proliferative and bacterial activities. Fluorescence quenching studies and synchronous spectra were used to examine the metal complexes interactions with CT‐DNA and BSA protein. The DNA binding study have revealed that the complexes are capable of binding with DNA via intercalative mode. The antimicrobial activity of the ligand and metal complexes was studied against three Gram‐positive bacteria, two Gram‐negative bacteria, and three strains of fungi. The best antibacterial effect was demonstrated by the Pt(II) complex on the Staphylococcus aureus strain, and as for the inhibitory effect on fungi, it was stronger on the Candida albicans strain after treatment with the Co(II) complex. The in vitro antiproliferative activity of ligand and complexes was analyzed using MTT, Annexin V/PI, and cell cycle assays. The in vitro results showed that, except for Pd(II) complex, where slight effects were observed, the MCF‐7 line was resistant to the activity of the complexes. In the case of A549 cells, Cu(II) and Pd(II) complexes showed a dose‐dependent antitumor activity, confirmed by both the Alamar blue and the Annexin V/PI analysis. Finally, the antioxidant activity of the compounds was examined by ABTS and DPPH methods. Antioxidant investigation showed that the Ni(II) complex possesses a remarkable ability to trap the cation of the ABTS+ radical (IC50 value 9.35 μM).

DNA interaction and cytotoxicity of a new asymmetric dimer cobalt(II) complex [Co(phen)2(Cl2)]3(H2O).[Co(phen)2(Cl)(H2O)](Cl)

The new, unusual and asymmetric cobalt(II) complex, [Co(phen)2(Cl2)]3(H2O).[Co(phen)2(Cl)(H2O)](Cl) (phen ​= ​1,10-phenanthroline), has been synthesized and characterized structurally by regular spectral and single crystal XRD analysis. An asymmetric complex crystallized in a monoclinic system with space group P21/c, a ​= ​14.093(5) Å, b ​= ​24.089(5) Å, c ​= ​14.241(5) Å, α ​= ​90.000(5)°, β ​= ​98.010(5)°, and γ ​= ​90.000(5)°. DNA binding interactions of complex with calf thymus DNA (CT-DNA) has investigated by UV–Vis absorption, ethidium bromide displacement assay, viscometric and cyclic voltammetric titrations, and the results infer an intercalation mode of binding. Complex cleaves effectively plasmid pBR322 DNA, and exhibits remarkable cytotoxic activity against human colon cancer cell line (HCT15).

Cobaltabis(dicarbollide) Interaction with DNA Resolved at the Atomic Scale.

Boron neutron capture therapy represents a promising avenue for cancer treatment that requires nontoxic drugs with a high boron content efficiently distributed into cancerous cells. The metallacarborane o-cobaltabis(dicarbollide) ([COSAN]-) fulfills these requirements and constitutes an attractive candidate. Nevertheless, the interaction of this promising drug with nucleic acids, the assumed target of the biological damage, is poorly understood since contradictory results are reported in the literature. This work establishes the DNA/[COSAN]- interaction strength, mechanism, and time scale at the atomistic level by using a combination of microsecond-molecular dynamics and hybrid quantum mechanics/molecular mechanics simulations and by quantifying the absolute binding free energy. Results show that the DNA/[COSAN]- interaction is highly dependent on the ionic strength of the medium. A relatively weak DNA major groove binding (ΔGbind= -2.49 kcal/mol) driven mostly by dihydrogen B-H···H-N bonding is observed in the simulations only at a high NaCl concentration, whereas DNA intercalation mode is deemed highly unlikely.

Nucleic acid binding affinity and antioxidant activity of N-m-Tolyl-4-Chlorophenoxyacetohydroxamicacid.

Hydroxamic acids represent a group of weak organic acids, both naturally occurring and synthetically derived, characterized by the general formula RC(= O)N(R'OH). In this study, we investigated the binding behavior of N-m-tolyl-4-chlorophenoxyaceto hydroxamic acid with calf thymus DNA (ct-DNA) and torula yeast RNA (t-RNA) through a combination of techniques including UV-visible spectroscopy, fluorescence emission analysis, viscometry, and computational simulations using AutoDock4 software. Our findings reveal that the mode of binding between the compound and the nucleic acids is consistent with intercalation. Competitive binding experiments demonstrated that the complex competes effectively with ethidium bromide (EB) for binding to ct-DNA/t-RNA, displacing EB from its binding sites. Additionally, the introduction of the compound into the DNA-EB system resulted in a quenching of fluorescence emission peaks. Analysis of absorption spectra indicated a red shift and hypochromic shift when the compound interacted with DNA, further supporting the intercalative binding mode. The calculated binding constant (Kb) value for the compound is 6.62 × 104M-1 and 5.40 × 103M-1 indicating a strong interaction with ct-DNA and t-RNA respectively. We determined the Stern-Volmer constants for ct-DNA and t-RNA as 9.96 × 104M-1 and 8.13 × 105M-1, respectively. The binding free energy values for ct-DNA/t-RNA were calculated to be -3.741 × 107 and -5.425 × 108kcal/mol, respectively. Viscometric studies corroborated the UV results, showing a continuous increase in relative viscosity of ct-DNA/t-RNA solutions with the addition of the optimal hydroxamic acid concentration. Furthermore, we assessed the antioxidant activity of the compound using DPPH-radical scavenging and β-carotene linoleic acid assays. Gel electrophoresis results demonstrated the compound's remarkable efficacy in preventing DNA damage. Collectively, all experimental evidence supports the conclusion that N-m-tolyl-4-chlorophenoxyaceto hydroxamic acid binds to ct-DNA/t-RNA through an intercalative mechanism, which is consistent with our molecular docking simulations.

Trivalent transition metal ion mediated template synthesis: In silico molecular docking, DNA binding, antimicrobial evaluation and DFT studies

In order to reduce the chances of multiple drug resistance, there is an urgent requirement for the designing of new antimicrobial agents. In this current research, series of novel hexaazamacrocyclic trivalent transition metal complexes of ChromiumIII and IronIII have been prepared by adopting the pathway of metal ion mediated template condensation. The newly synthesized macrocyclic complexes were analyzed by Infra-Red Spectroscopy, Carbon-Hydrogen-Nitrogen analyzer, UltraViolet–visible, Powder X-Ray Diffraction, Electron Paramagnetic Resonance, Magnetic Susceptibilities, Molar conductance, Electron Spray Ionisation-Mass Spectrometry and Thermogravimetric analysis techniques. The electro-lytic behaviour of the complexes was suggested by conductance (molar) values. All the complexes (T7-T12) can be formulated or represented as [MLX] X2·yH2O, where M = FeIII, CrIII and L is the macrocyclic ring resulting from 1,8-diaminonaphthalene and succinimide and X = NO3−, Cl−, CH3COO− and y = 1 or 2. All the macrocyclic complexes have been anticipated to have a penta coordinated square pyramidal shape using several physico-analytical approaches. Monomeric nature of the complexes was confirmed by CHN analysis and mass spectral data. Powder X-Ray Diffraction studies were carried out for interpreting the crystallinity of the complexes. Density Functional Theory studies were performed for energy optimization and theoretical calculations of UV & IR. The DNA interaction studies showed intercalative mode of binding is present in the newly designed complexes with the DNA. In addition to these, all the metal complexes were screened for their antibacterial and antifungal activity against pathogenic strains of bacteria and fungi, Complex T7 has effective bactericidal action against B. cereus and E. coli. Molecular docking studies were also performed on SARS Cov-2 and Mycobacterium tuberculosis. The used proteins are NSP15 Endoribonuclease from SARS CoV-2 and DNA of Mycobacterium tuberculosis H37Rv. The results revealed that complex T10 is having good binding affinity against DNA of Mycobacterium tuberculosis H37Rv.

A series of DNA targeted Cu (II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity

Copper(II) complexes are very promising candidates for platinum-based anticancer agents. Herein, three Cu (II) complexes (1–3) containing 1,8-naphthalimide ligands were synthesized and characterized by FT-IR, elemental analysis, ESI-MS and single crystal X-ray diffraction (complex 3). In addition, a control compound (complex 4) without 1,8-naphthalimide ligand was synthesized and characterized. The in vitro anticancer activity of the synthesized complexes against five cancer cell lines and one normal cell line was evaluated by MTS assay. The results displayed the antitumor activity of complexes 1–3 was controlled by the aliphatic chain length of ligands, their cytotoxicity was in the order 3 > 2 > 1, giving the IC50 values ranging from 2.874 ± 0.155 μM to 31.47 ± 0.29 μM against five cancer cell lines. Complex 4 showed less activity in comparison with complex 1–3. Notably, complexes 1–3 displayed much higher selectivity (SI = 2.65 to 10.16) compared to complex 4 (SI = 1.0), indicated that the introduction of 1,8-naphthalimide group not only increased the activity of this series of compounds but also enhanced their specific selectivity to cancer cells. Compound 3 induced apoptosis in cancer cells and blocked the S-phase and G2/M of cancer cells. The interaction with DNA of complexes 3 and 4 was studied by UV/Vis spectroscopic titrations, competitive DNA-binding experiment, viscometry and CD spectra. The results showed that complex 3 interacted with DNA in an intercalating mode, but the interaction mode of compound 4 with DNA was electrostatic interaction.

Synthesis, spectral, in silico/molecular docking and pharmacological studies of biologically potent triorganotin(IV) carboxylates

A series of compounds containing a glutaric anhydride-based carboxylate ligand (LH) and three triorganotin derivatives R3SnL for R = Me (1), nBu (2), and pH (3) are described in this article. The synthesis of the compounds was confirmed by microelemental CHN analysis, FT-IR, NMR and in the case of LH, 1 and 2 by single crystal X-ray crystallography, revealing the formation of one-dimensional coordination polymers for 1 and 2 with trans-C3O2 trigonal-bipyramidal geometries for the tin(IV) atoms. The anti-microbial activity was explored with the MIC values of 2 (≤ 0.25 µg/mL against the bacterium S. aureus and fungal strains C. albicans and C. neoformans) being less than observed for the anti-bacterial drug vancomycin-HCl (1 μg/mL) and anti-fungal drug fluconazole (≤ 0.25 and 8 μg/mL, respectively). The maximum cytotoxicity was observed for 2, against the human embryonic kidney (HEC239) cell line, with CC50 ≤ 25 μg/mL. An evaluation of the compound-DNA interactions was performed through UV–Visible spectroscopic and viscometric experiments, with the observation of hypochromic along with slight bathochromic shifts and an increase in viscosity, respectively, revealing an intercalative mode of interaction. In comparison with the standard anti-oxidant ascorbic acid, the greatest scavenging of DPPH was recorded for 3 followed by 2, 1 and LH. The human malignant glioma cell line (MG-U87) was used to explore the anti-cancer potential of the synthesised compounds. Compounds 3 and 2 (IC50 = 5 and 21 µM, respectively) showed encouraging results when compared to cisplatin (IC50 = 133 µM). The anti-leishmanial data shows that at a 1000 µg/mL dose, the greatest percentage inhibition was observed for 2 (87.15 ± 0.01 %) which is almost equivalent to that for amphotericin B (90.67 ± 0.15 %). The docking results with SS-DNA revealed the compounds undergo an intercalative mode of interaction with the nitrogenous bases adenine, guanine and cytosine, with docking score order: 3 (-8.11) > 2 (-8.02) > 1 (-6.99) > LH (-6.38). Similarly, the docking results against the Brest cancer receptor BRCA2, indicate the highest binding score was observed for 3. The anti-leishmanial docking data indicates 2 as having maximum docking score (-7.79). The in silico study, performed to reveal the drug-likeness behaviour of the news compounds, suggest that they possess the properties of orally active drugs.

Indium(III) complexes with lapachol: cytotoxic effects against human breast tumor cells and interactions with DNA.

Lapachol (2-hydroxy-3-(3-methylbut-2-en-1-yl)naphthalene-1,4-dione) is a 1,4-naphthoquinone-derived natural product that presents numerous bioactivities and was shown to have cytotoxic effects against several human tumor cells. Indium(III) complexes with a variety of ligands also exhibit antineoplastic activity. Indium(III) complexes [In(lap)Cl2].4H2O (1), [In(lap)2Cl(Et3N)] (2), [In(lap)3]·2H2O (3) [In(lap)(bipy)Cl2] bipy = 2,2'-bipyridine (4) and [In(lap)(phen)Cl2] phen = 1,10-phenanthroline (5) were obtained with 2-hydroxy-3-(3-methylbut-2-en-1-yl)naphthalene-1,4-dione (lapachol). Crystal structure determinations for (4) and (5) revealed that the indium(III) center is coordinated to two O atoms from lapachol, two N atoms from 1,10-phenanthroline or 2,2'-bipyridine, and two chloride anions, in a distorted octahedral geometry. Although both complexes (4) and (5) interacted with CT-DNA in vitro by an intercalative mode, only 5 exhibited cytotoxicity against MCF-7 and MDA-MB breast tumor cells. 1,10-phenanthroline and complex (5) presented cytotoxic effects against MCF-7 and MDA-MB cells, with complex (5) being threefold more active than 1,10-phenanthroline on MCF-7 cells. In addition, complex (5) significantly reduced the formation of MDA-MB-231 colonies in a clonogenicity assay. The foregoing results suggest that further studies on the cytotoxic effects and cellular targets of complex (5) are of utmost relevance.

Synthesis, Characterization, DNA, Fluorescence, Molecular Docking, and Antimicrobial Evaluation of Novel Pd(II) Complex Containing O, S Donor Schiff Base Ligand and Azole Derivative

Pd(II) with the Schiff base ligand 2-Hydroxy-3-Methoxy Benzaldehyde-Thiosemicarbazone (HMBATSC) (L2) and 2-aminobenzothiazole (2-ABZ) (L1) was synthesized. The Schiff base ligand and the Palladium(II) complex were characterized by C.H.N.S, FT-IR, conductance studies, magnetic susceptibility, XRD, and TGA. From the elemental analysis and spectral data, the complex was proposed to have the formula [Pd(HMBATSC)(2-ABZ)H2O]. The interaction between the Pd(II) complex and DNA was examined through various methods, including UV–Vis spectroscopy, fluorescence techniques, and DNA viscosity titrations. The findings provided strong evidence that the interaction between the Pd(II) complex and DNA occurs through the intercalation mode. The analysis yielded the following values: a Stern–Volmer quenching constant (ksv) of 1.67 × 104 M−1, a quenching rate constant (kq) of 8.35 × 1011 M−1 s−1, a binding constant (kb) of 5.20 × 105 M−1, and a number of binding the sites (n) of 1.392. DFT studies suggest that the azole derivative may act as an electron donor through pyridine nitrogen, while the Schiff base ligand may act as an electron donor via oxygen and sulfur atoms. TDDFT calculations indicate that the intramolecular charge transfer from the Schiff base to Pd(II) is responsible for the complex’s fluorescence quenching. The powder X-ray diffraction data revealed that the complex is arranged in a monoclinic system. The resulting Pd(II) complex was investigated for its antimicrobial activity and demonstrated antibacterial efficiency. Interestingly, it showed potent activity against E. coli and E. niger that was found to be more powerful than that recorded for Neomycin.

Synthesis, optical properties, DNA, β-cyclodextrin interactions, and antioxidant evaluation of novel isoxazolidine derivative (ISoXD2): A multispectral and computational analysis

ISoXD2 are well explored among versatile and outstanding class of pharmacophores for the preparation and discovery of drugs. Herein, the electronic absorption and emission spectra of ISoXD2 were investigated in three different solvents. The observed transition was attributed to π-π* with charge transfer character. Changes in the excited state and shift of the absorption and emission peaks to longer wavelengths are observed as a result of increasing solvent polarity, due to the interactions between the ISoXD2 molecule and the solvent molecules surrounding it. Changing the solvent confirms its solvatochromic effect. UV–vis and fluorescence analysis revealed that ISoXD2 binds to deoxyribonucleic acid (DNA) by intercalation mode, with a stoichiometric ratio of 1:1.5. Moreover, the fluorescence intensity of DNA bound to ethidium bromide (EB) in the presence of ISoXD2 was investigated. From this analysis, the Stern-Volmer quenching constant (Ksv), quenching rate constant (kq), binding constant (Kb) and binding sites number (n) were found to be 5.654 × 103 M−1, 2.827 × 1011 M−1 s−1, 3.81 × 104 M−1 and 1.225, respectively. The interaction between ISoXD2 and β-CD was investigated through absorption spectra analysis. Kb for this interaction was determined to be 4.9 × 104 M−1. The free radical-scavenging ability of the prepared ISoXD2, examined by DPPH and ABTS assays have shown a good antioxidant activity. Furthermore, modeling study was conducted to explore their plausible binding mechanism with ISoXD2 and to support the experimental results.

Poly-Eriochrome Black T Decorated with Nickel Hydroxide Nanoparticles Modified Electrode for the Electrochemical Detection of Streptomycin and Probing its Interaction with Double-stranded DNA

We present a simple platform of poly-eriochrome Black T decorated with nickel hydroxide nanoparticles (Ni(OH)2NPs/PEBT) for the electrocatalytic oxidation of streptomycin (STRP) and probing its interaction with double-stranded DNA (ds-DNA). The electropolymerized eriochrome Black T modified glassy carbon electrode (GCE) was used to stabilize and synthesize Ni(OH)2NPs. The oxidation of STRP on Ni(OH)2NPs/PEBT/GCE mainly proceeded as a surface mechanism with the contribution of a diffusion-controlled process. A significant catalytic oxidation current of STRP was measured from an alkaline medium. It showed a dependence on the STRP concentrations in the range of 0.1 to 1.0 mM with a detection limit of 0.04 mM. The sensor has shown good recovery (85.3% to 90.2%, with RSD range of 1.27 to 8.83%) for the detection of STRP in diluted human serum. The interaction of STRP with ds-DNA was investigated from phosphate buffer pH 7.4 (0.2 M) using different electrode modifications (PEBT/GCE, and Ni(OH)2NPs/PEBT) in addition to bare GCE using voltammetric and impedance techniques. The binding constant of the STRP-DNA complex was calculated. Under the studied conditions, the interaction of ds-DNA with STRP in solution or on the surface of PEBT/GCE demonstrates their binding in intercalative and electrostatic modes.

Synthesis, characterization, biomolecule-binding and preliminary anticancer properties of PtCl(N^N^O) with naphthalenyl-containing tridentate ligand

A tridentate Schiff base ligand was synthesized via the reaction of 2-hydroxynpthaldehyd with N-phenyl-o-phenylenediamine. The obtained ligand was utilized in synthesizing Pt-L2 [PtCl(N^N^O)]. The ligand and Pt-L2 were characterized by IR, NMR and mass spectroscopies as well as elemental analysis. The DNA-binding of Pt-L2 was examined by fluorescence quenching using the EB-DNA adduct method. The apparent affinity for the compound toward ct-DNA was nearly twice the affinity of ethidium bromide. Changes in the relative viscosity induced by platinum complexes of ct-DNA indicated an intercalation mode of binding for Pt-L2 and covalent binding for the second platinum compound, Pt-L1, synthesized from 3-ethoxysalicyaldehyde and N-phenyl-o-phenylenediamine. BSA-binding by Pt-L2 indicated the spontaneous formation of an adduct with the protein with good binding affinity (7.7 × 104). The anticancer activities of Pt-L2 were evaluated against two cancer cell lines and compared to that of Pt-L1 and cisplatin. Pt-L2 has better IC50 values, possibly because of its highly π-delocalized planar system. Moreover, selectivity index for Pt-L2 is high (SI = 168) which is one of the criteria for potential chemotherapeutic agents (higher than that observed for cisplatin (SI = 37)).

Chemical Composition and Protective Possibilities of Juglans Nigra Leaves and Green Husks Extracts: DNA Binding and Micronucleus Assay in Human Lymphocytes.

To better understand the mechanism of action of the compounds in the ethanolic extracts of J. nigra leaves and green husks, their binding to CT-DNA was investigated. This study was conducted to elucidate the in vitro protective effect of extracts against chromosomal damage in mitogen-induced human lymphocytes and investigate the possible application of selec+ted extracts as a natural source of polyphenolic compounds. Using HPLC-MS analysis, 103 different compounds were identified as having a higher number of active species, which is consistent with their activity. The frequency of micronuclei (MN) was scored in binucleated cells, and the nuclear proliferation index was calculated. Cyclic voltammetry experiments demonstrate that the nature of the interaction between extracts and CT-DNA is a synergy of electrostatic and intercalative modes, where leaves extracts showed a higher ability to bind to DNA. Extracts showed excellent antioxidant activity. At a concentration of only 4 µg/mL, extract of J. nigra leaves and the green husks reduced the incidence of MN by 58.2% and 64.5%, respectively, compared to control cell cultures.

Aroylhydrazone‐based nickel(II) complexes: Synthesis and their structural, density functional theory (DFT), biological and catalytic studies

Nickel(II) complexes of tridentate NNO donor aroylhydrazones, viz., di‐2‐pyridyl ketone‐4‐methoxybenzhydrazone monohydrate (DKMBH·H2O) and 2‐acetylpyrazine‐4‐methoxybenzhydrazone monohydrate (APMBH·H2O), were synthesized and characterized using various methods, including spectral techniques (Fourier transform infrared [FT‐IR], UV–vis) and analytical methods (elemental and X‐ray diffraction [XRD] analysis). Single‐crystal XRD was used to elucidate the crystal structures of nickel(II) complexes 1 and 2. The XRD analysis revealed that the respective ligands coordinated to the Ni(II) center through the deprotonated iminolate form in complex 1 and the neutral amido form in complex 2, resulting in distorted octahedral geometries. The ground state electronic configurations of the complexes were studied using the B3LYP/UB3LYP levels of DFT. Using absorption spectral titration methods, the interactions of complexes with CT‐DNA and bovine serum albumin (BSA) protein were examined. The observed data demonstrate that the complexes adopt an intercalative binding mode to bind to CT‐DNA and BSA protein. Additionally, the antioxidant activity of the nickel(II) complexes and their ligands was determined using 1,1‐diphenyl‐2‐picrylhydrazyl (DPPH). Complex 2 demonstrated the highest radical scavenging activity of the compounds studied (IC50 = 3.81 mM). Furthermore, molecular docking studies were performed to understand how the complexes can interact with the SARS‐CoV‐2 main protease. The results revealed that complex 2 had the highest docking score (−8.18 kcal/mol) when compared with the other complexes under study. Aside from their biological properties, the nickel complexes heterogenized on functionalized SBA‐15 showed promising catalytic activity, achieving 98% yield in the reduction of nitrobenzene, forming exclusively aniline as the end product.

Novel 5-(2-chloro-quinolin-3-yl)-[1,3,4]thiadiazol-2-ylamines and their copper(II) metallates: Preparation, spectroscopy, X-ray crystallography, nucleic acid/albumin binding, DNA cleavage and in vitro cytotoxicity

Copper(II) metallates of 2-chloroquinoline-3-carboxaldehyde-4(N)-substituted thiosemicarbazone (CuQ1, CuQ2, CuQ3, CuQ4) were synthesized, characterized by Fourier-Transform Infrared (FT-IR), Ultraviolet–Visible (UV–Vis), Electron Paramagnetic Resonance (EPR) and Mass spectrometry. The true nature of the ligands and a representative complex was confirmed by X-ray single crystal analysis. During the complexation, the ligands underwent cyclisation to form thiadiazole and two units of thiadiazole were coordinated to copper ion through N2-nitrogen atom. The remaining sites were occupied with two chloride ions and a water molecule which led to a square pyramidal geometry around copper ion. Absorption and emission titration methods confirmed the partial intercalative mode of binding interaction between CT-DNA and the metal complexes. The interaction between complexes and BSA led to the formation of ground state fluorophore-quencher complex by following static quenching mechanism. In vitro cytotoxic effect of the ligands and complexes were done by taking Human cervical cancer (HeLa) cells and toxicity of the test compounds were analyzed by using normal human kidney cell (HEK). The complexes CuQ2, CuQ3 and CuQ4 showed better cytotoxic activity against HeLa cells as compared with the standard cisplatin. Among the complexes, CuQ3 exhibited higher activity with least IC50 value (17 µM).

Copper complexes with quinoline-thiosemicarbazone hybrid ligand promoting apoptosis by causing DNA and mitochondria dual lesions

The copper ion and thiosemicarbazone group are well known for their biological activity, endowing the thiosemicarbazone copper complexes with medicinal perspectives. In this work, two copper complexes [Cu(qcpt)(PPh3)2Br]·2CH3CN (1) and [Cu2(qcapt)(Ac)2(CH3O)] (2) derived from the bioactive quinoline-thiosemicarbazone conjugate (qcpt = quinoline-2- carboxaldehyde-4-pyridine-3-thiosemicarbazone; qcapt = quinoline-2-carboxaldehyde acid-4- pyridine-3-thiosemicarbazone) were rationally synthesized and characterized by single crystal X-ray diffraction, Infrared (IR) spectroscopy, X-ray photoelectron spectroscopy (XPS), and etc. In vitro antitumor studies suggested that complexes 1 and 2 showed effective anti-proliferative activity against malignant tumor cells, especially for complex 1 that exhibited the most sensitive against SMMC7721 cells (human liver carcinoma cell lines). Further, mechanistic studies showed that complex 1 could readily enter the cells, block the cell cycle, cause mitochondrial dysfunction and ATP depletion, enhance the levels of intracellular reactive oxygen species (ROS), and eventually trigger cell death via apoptosis. Additionally, complex 1 bound to CT-DNA via an intercalation mode as evidenced by spectroscopic experiments, molecular docking study and cleaved pBR322 DNA efficiently in the presence of H2O2.

Biological and equilibrium studies of Co(II), Cu(II), Zn(II), and Cd(II) complexes of 1‐formyl‐3‐semicarbazide: Docking studies

1‐Formyl‐3‐semicarbazide (FSC, HL) and its metal complexes with Co(II), Cu(II), Zn(II), and Cd(II) ions have been synthesized and characterized by elemental analysis, liquid chromatography‐mass spectrometry (LC–MS), infrared (IR), electronic, nuclear magnetic resonance (NMR) and electron spin resonance (ESR) spectroscopy, thermogravimetric analysis (TGA), magnetic susceptibility, and conductivity measurements. The chelates are non‐electrolytic in nature with distorted octahedral geometry. The kinetic and thermodynamic properties were calculated using the Coats–Redfern relation results in positive enthalpy change values and negative entropy change values. The equilibrium studies of FSC with Co(II), Zn(II), and Cd(II) ion have been carried out by potentiometric pH titrations in 70% v/v DMF‐water medium at 303 K and 0.1 M (KNO3) ionic strength. The study revealed that FSC is monobasic acid with pKa value of 8.84. The stability constants suggested the formation of 1:1 Co(II)‐FSC complex, and Zn(II)‐FSC and Cd(II)‐FSC systems revealed the formation of both 1:1 and 1:2 complexes in the solution. DNA binding studies for the metal chelates have been carried out using electronic absorption spectra, fluorescence emission spectra, and viscosity measurements revealing groove binding for Co(II), and Zn(II) complexes, and intercalation mode of binding for Cu(II)‐FSC complex with CT‐DNA. The Kb values from absorption studies are Co(II)‐FSC = 0.9990 × 102, Cu(II)‐FSC = 2.433 × 104, and Zn(II)‐FSC = 8.277 × 102 M−1, and the KSV values from the competitive fluorescence emission studies are Co(II)‐FSC = 0.19212 and Cu(II)‐FSC = 0.11482 M−1. Molecular docking carried out for both ligand and its Co(II) and Zn(II) complexes also revealed groove mode of binding, and Cu(II) complex showed intercalative mode of binding. The inhibition constants for HL, Co(II), Cu(II), and Zn(II) are 1460, 0.478, 0.122, and 0.194 μM, respectively. The antimicrobial activity has been studied using agar disk diffusion method against Escherichia coli and Bacillus subtilis. FSC has been found to be more active against gram +ve and gram –ve bacteria than its metal chelates.

Experimental biological studies of novel tetradentate hydrazone Cu(II) complexes for potential applications in medicinal chemistry

A series of mononuclear Cu(II) complexes were synthesized using a potential tetradentate hydrazone ligand obtained from the reaction between phenylhydrazine groups and 2,5-thiophenedicarboxaldehyde. The structures of ligands and complexes were elucidated through various spectroscopic techniques, confirming their composition. All complexes were found to adopt four-coordinated geometries, indicating the formation of stable structures. Spectroscopic analysis revealed that the hydrazone ligand coordinated with the Cu(II) metal ions as a dibasic tetradentate ligand by utilizing the phenolic oxygen and azomethine nitrogen atoms. The binding affinity of the complexes with calf thymus DNA (CT-DNA) was investigated using absorption and viscosity measurements, demonstrating their interaction through the intercalation mode. The binding studies showed that the Cu(II) complexes exhibited varying degrees of binding affinity, with Cu(L4) demonstrating the highest affinity, followed by Cu(L1), Cu(L2), and Cu(L3). Moreover, the DNA fragmentation properties of the Cu(II) complexes were evaluated, suggesting their potential utilization in pharmaceutical applications. The obtained results highlight the significance of these novel complexes in the field of medicinal chemistry.

Antibacterial potentials and DNA study of cobalt(II) complexes containing aminophenol Schiff base moiety

The present study was carried out to investigate the effect of substituent groups on the antibacterial activities of 2-aminophenol Schiff bases and their cobalt (II) complexes. Development of new compounds with potential effects against pathogenic organisms has become necessary due to the increase in microbial resistance reported for existing antiseptics and disinfectants. In line with this, new cobalt (II) complexes with Schiff bases derived from 2-aminophenol and p-substituted benzaldehydes were synthesized. The compounds were characterized using elemental analysis, mass spectrometry, atomic absorption spectroscopy, electrospray ionization mass spectrometry, infrared spectroscopy, 1H NMR and electronic absorption spectroscopy. Results indicate that all metal complexes had a 1:2 metal ligand ratio with magnetic moments characteristic of tetrahedral geometry around the metal ion. The Schiff bases and their metal complexes were screened for in-vitro antibacterial activities against 6 human pathogenic bacteria usually found around the hospitals and homes; Escherichia coli (ATCC 8739), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 19582), Bacillus cereus (10702), Enterococcus faecalis (ATCC 29212) and Kribsella pneumonia (ATCC 10031) with ampicillin used as the reference compound. DNA binding study using calf thymus DNA revealed intercalative mode of activity. The result showed that Schiff bases exhibited moderate inhibitory activity against the tested microorganisms while Schiff base metal complexes exhibited higher antibacterial activity when compared to ampicillin. Our results indicate that these complexes can be employed as active ingredients in development of broad-spectrum antibacterial agents.

Studies on interactions of ruthenium(II) polypyridyl complexes [Ru(bpy)2(btip)]2+ and [Ru(dmb)2(btip)]2+ with double-stranded RNA poly(A)·poly(U) under molecular crowding conditions

Ruthenium(II) polypyridyl complexes have emerged as excellent nucleic acid binders based on the easy-to-construct three-dimensional structures and rich photophysical and photochemical properties. However, most studies are usually performed under dilute conditions, which might be disturbed by the crowding environment of cells. Herein, two ruthenium(II) polypyridyl complexes, [Ru(bpy)2(btip)]2+ (Ru1, bpy = 2,2′-bipyridine, btip = 2-benzo[b]thien-2-yl-1H-imidazo[4,5-f]-[1,10]phenanthroline) and [Ru(dmb)2(btip)]2+ (Ru2, dmb = 4,4′-dimethyl-2,2′-bipyridine) have been synthesized and characterized. Interactions of the two complexes with double-stranded RNA poly(A)·poly(U) in dilute solution and molecular crowding environment have been studied by spectroscopic techniques and viscosity measurements, respectively. Spectral titration and viscosity experiments show that both Ru1 and Ru2 combine with poly(A)·poly(U) through an intercalative mode in both environments, and the binding affinity in crowding environment is significantly lower than that in dilute solution, but still comparatively high. Moreover, thermal denaturation experiments show that the abilities of Ru1 and Ru2 to poly(A)·poly(U) are significantly reduced under crowding condition, which are attributed to the reduced binding affinity of the complexes to poly(A)·poly(U) in crowding environment.